The Biomedical Research Networking Center (CIBER) is a Public Research Consortium created in 2006 under the leadership of the Carlos III Health Institute (ISCIII, the main Public Research Entity responsible of funding, managing and carrying out biomedical research in Spain), to promote research excellence and build a critical mass of researchers in the field of Biomedicine and Health Sciences. Organized in 8 research areas including Bioengineering, Biomaterials and Nanomedicine (CIBERBBN), Mental Health (CIBERSAM), Hepatic Diseases (CIBEREHD), Diabetes and Metabolic Diseases (CIBERDEM), Rare Diseases (CIBERER), Respiratory Diseases (CIBERES), Public Health and Epidemiology (CIBERESP) and, Obesity and Metabolic Diseases (CIBEROBN), CIBER is the largest Research Network in Spain.
CIBER counts with more than 830 dedicated employees and 4,000 associated researchers integrated in 399 leading-edge research groups. Thanks to its network structure, CIBER is capable of bringing together more than 92 different associated institutions including Hospitals, Research Centers, Technology Centers, Private Institutions and Universities selected to join CIBER consortium on the basis of their excellence.
The CIBER-BBN (www.ciber-bbn.es) is the research area devoted to the study of Bioengineering, Biomaterials and Nanomedicine. Organized in three research areas: i) Bioengineering & Medical Imaging includes research groups devoted to the studies of Multimodal Diagnosis and Intelligent Devices & Biomedical Systems, ii) the area of Biomaterials & Advanced Therapies including lines on Cell and Gene Therapy, Tissue Engineering and Prostheses and Implants, while iii) the area of Nanomedicine includes among their research groups those devoted to the study of Nanodiagnostics, Therapeutic Nanosystems and Nanobiotechnology.
CIBER-BBN, employs nearly 100 researchers directly hired by CIBER and conduct their research at any of the 44 participating groups, as well as more than 350 associate researchers, who although having a contract with the corresponding consortium institution they are considered as attached-to-CIBER staff. The CIBER-BBN brings together some of the main Spanish research groups in the fields of Bioengineering, Biomaterials and Nanomedicine, including both universities and hospitals and other technological or research centers. Its purpose is to conduct translational research and to transfer the results to industry. The bioengineering, biomaterials and nanomedicine area is made up of more than forty research groups, keeping its independence as regards scientific management. Its organisational structure is based on the research groups belonging to this and its activity revolves around the Research Programmes and Transversal Programmes, with a coordinator for each Programme belonging to the Steering Committee. Scientific decisions are made by the Scientific Director, advised by said Steering Committee and the External Scientific Committee. The Steering Committee is presided over by the Scientific Director and made up of the coordinators of the programmes and Managing Director of the CIBER.
For more information please visiti CIBER-BBN website
